| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $325.1M | -0.3% |
| Cost of Revenue | $98.5M | -4.5% |
| Gross Profit | $226.6M | +1.6% |
| R&D Expense | $95.3M | -3.1% |
| SG&A Expense | $70.1M | -23.2% |
| Operating Income | -$30.8M | +25.1% |
| Pre-tax Income | -$13.4M | +45.2% |
| Income Tax | $2.2M | +8.4% |
| Net Income | -$15.6M | +41.2% |
| EPS (Basic) | -$0.17 | +34.6% |
| EPS (Diluted) | -$0.17 | +34.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $25.0M | -83.8% |
| Accounts Receivable | $2.2M | -22.3% |
| Current Assets | $552.5M | -22.4% |
| Total Assets | $752.3M | -17.6% |
| Current Liabilities | $366.4M | +2.5% |
| Long-term Debt | $240.7M | -32.7% |
| Total Liabilities | $582.1M | -19.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.6M | +87.0% |
| Capital Expenditures | $600K | -45.3% |
| Investing Cash Flow | $123.9M | +278.7% |
| Financing Cash Flow | -$177.5M | -3515.9% |
| Free Cash Flow | $35.0M | +95.2% |
| Stockholders' Equity |
| $170.2M |
| -11.2% |